Overview:

Respiratory gating systems are non-invasive guidance systems used for targeting tumors in internal organs such as lungs, in abdomen and breast with positioning radiation beam on the site. Tumors in internal organs tend to displace every time a patient breaths, thus making radiation therapy administration a challenge. Respiratory gating systems assist in monitoring the movement of target location corresponding to the patient’s breathing cycle. These solutions record the wave pattern of the respiratory cycle and determine precise tumor movement corresponding to the wave pattern. In advanced treatment techniques such as intensity modulated radiation therapy (IMRT) or image-guided radiation therapy (IGRT), respiratory gating systems are widely relied on by clinicians to monitor and compensate for tumor movement, this delivering more radiation doses.

It is often opined that assembling respiratory gating systems with the advanced adaptive radiotherapy and that the gated treatment delivery should be seed as the initial form of adaptive radiotherapy. Respiratory gating systems also hold significant potential in radiation therapy in cases where tumor shape change is a big issue. One major challenge to the growth of this market is that performing respiratory gating on LINAC systems is time-consuming and is not covered by incremental reimbursement. As against respiratory gating, adaptive radiotherapy is performed real-time, thereby removing the need to follow gating process. The margins of error in respiratory gating are also higher than adaptive radiotherapy (3 to 5 mm), which means more amount of healthy tissue is affected by treatment. Significant growth in incidence and prevalence of lung and breast cancer is the prime factor driving the demand for respiratory gating systems. Lung cancer, being the most common form of cancer prevalent worldwide, has the highest influx of radiotherapy. Incorporation of advanced technologies such as the 4D visualization has further increased the precision of gating systems and therefore augmented market opportunities.

The global Respiratory Gating Systems market is segmented on the following bases:

• Products
  • Respiratory Gating Systems
  • Accessories
• Usage Areas
  • Hospitals
  • Ambulatory Surgical Centers
• Geography
  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
  • The Middle East and Africa
    • GCC
    • Rest of the Middle East and Africa

Key players identified for Respiratory Gating Systems market include but are not limited to:

Siemens Healthcare, BrainLAB, Inc., Varian Medical Systems, Anzai Medical Co. Ltd., Raditec Medical AG, Philips Healthcare, Standard Imaging Inc., General Electric Company and others.

This report offers:

• Analysis of products, usage areas, and regions that would provide a clear understanding of the ongoing and future trends in the global respiratory gating systems market
• Assessment of regional market trends and scrutiny of potential customer bases
• Analysis of the intensity of challenge posed by adaptive radiotherapy
• Analysis of market dynamics such as drivers, restraints, and opportunities prevalent in the market
• Quantitative assessment of the current market size and future estimations for the period from 2016 to 2026, along with CAGRs for the period from 2018 to 2026
• Company profiles highlighting key information about the imperative players operating in the global respiratory gating systems market